ALDOC and neoplasm: In terms of regulating the tumor immune microenvironment, the discovery of the ALDOC-PPAR-γ axis has opened up new avenues for targeted therapy, with PPAR-γ agonists exerting anti-tumor effects by regulating metabolic and inflammatory response pathways.41